Kane Biotech Inc. V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.

TSXV:KNE - Post by User

Kane Biotech Inc.

Bullboard Posts

Comment by CurlyMickon Mar 26, 2014 7:28pm

222 Views

Post# 22372861

RE:RE:NICE DEVELOPMENT

"The global healthcare company holds an option to obtain an exclusive, worldwide license to develop, commercialize and market certain oral and wound care technologies in the global animal health market."

Sure hope this "option" doesn't have an open-end date for crystallization. OKAY KANE....Get real and update us.

I am starting to get the niggling feeling that this company is moving the way so many other biotech and tech juniors have lately. The lack of an up-to-date website (actually seriously outdated investors portion) is another one of my other concerns.

If Thindal is out, most likely his company that provided $1.4 million in 2012 has sold their shares too.

GLTA

Bullboard Posts

NVIDIA becomes world’s most valuable company amid AI boom